Copyright
©2010 Baishideng.
World J Gastrointest Oncol. Jan 15, 2010; 2(1): 19-30
Published online Jan 15, 2010. doi: 10.4251/wjgo.v2.i1.19
Published online Jan 15, 2010. doi: 10.4251/wjgo.v2.i1.19
Figure 2 Pharmacodynamics during HIPEC after intravenous administration of 400 mg/m2 of 5-fluorouracil given simultaneously with intraperitoneal chemotherapy in 3 L of chemotherapy solution.
(Van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacology of perioperative 5-fluorouracil. Submitted for publication).
- Citation: Sugarbaker PH, Van der Speeten K, Stuart OA. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol 2010; 2(1): 19-30
- URL: https://www.wjgnet.com/1948-5204/full/v2/i1/19.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v2.i1.19